![Guy MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guy MacDonald
Ordförande på
SCYNEXIS, INC.
Förmögenhet: 12 130 $ per 2026-05-31
Profil
Mr. Guy MacDonald is a Chairman at SCYNEXIS, Inc. Mr. MacDonald was previously employed as an Executive Vice President-Operations by Idenix Pharmaceuticals LLC, a Vice President-Anti Infective & Hospital Products by Merck & Co., Inc., and a Chairman by Spring Bank Pharmaceuticals, Inc. He also served on the board at Tetraphase Pharmaceuticals, Inc. He received his undergraduate degree from the University Of Dundee.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SCYNEXIS, INC. 0,02 % | 2026-04-01 | 17 206 ( 0,02 % ) | 12 130 $ | 2026-05-31 |
Aktiva positioner av Guy MacDonald
| Företag | Position | Start |
|---|---|---|
| SCYNEXIS, INC. | Ordförande | 2015-06-04 |
Tidigare kända positioner av Guy MacDonald
| Företag | Position | Slut |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Verkställande Direktör | 2019-08-01 |
| SPRING BANK PHARMACEUTICALS, INC. | Ordförande | 2015-08-17 |
| IDENIX PHARMACEUTICALS INC | Verksamhetschef | 2008-01-01 |
| MERCK & CO., INC. | Företagsledare/Principal | 2003-01-01 |
Guy MacDonalds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
84
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
